Melittin Inhibits DU -145 Human Refractory Prostate Cancer Cell Growth Through Induction of Apoptosis Via Inactivation of NF-${\kappa}$B

Melittin이 NF-${\kappa}$B의 불활성화를 통한 DU-145 전립선 암세포의 성장 및 세포자멸사 유도에 미치는 영향

  • Choi, Chul-Hoon (Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Kyungwon University) ;
  • Song, Ho-Sueb (Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Kyungwon University)
  • 최철훈 (경원대학교 한의과대학 침구학교실) ;
  • 송호섭 (경원대학교 한의과대학 침구학교실)
  • Published : 2009.06.20

Abstract

목적 : 이 연구는 봉약침의 주요성분인 멜리틴이 NF-${\kappa}$B의 활성억제를 통하여 세포자멸사를 유도하고, 전립선 암세포주인 DU-145 세포의 성장을 억제하는지를 확인하고 멜리틴의 NF-${\kappa}$B 활성억제기전을 살펴보고자 하였다. 방법 : 멜리틴을 처리한 후 DU-145의 성장억제를 관찰하기 위해 WST-1 assay를 시행하였고, 세포자멸 사의 관찰에는 DAPI stairung assay를 통한 세포형태관찰을 시행하였으며, 염증관련유전자 발현 관찰에는 western blot analysis를 시행하였고, 세포자멸사와 연관된 NF-${\kappa}$B의 활성 변화를 관찰하기 위해 EMSA와 luciferase assay를 시행하였으며, DU-145에서 멜리틴과 NF-${\kappa}$B의 상호작용을 관찰하기 위해 transient transfection assay를 시행 시 세포생존율과 NF-${\kappa}$B의 활성 변동을 측정하였다. 결과 : DU-145 세포에 멜리틴을 처리한 후, 전립선암세포의 성장, 세포자멸사의 유발, 염중관련유전자 발현 및 NF-${\kappa}$B의 활성, NF-${\kappa}$B의 p50 치환 후 NF-${\kappa}$B의 활성과 DU-145 세포 증식에 미치는 영향을 관찰하여 다음과 같은 결과를 얻었다. 1. DU-145 세포에서 멜리틴을 처리한 후 세포자멸사가 유도되어 세포성장이 억제되었다. 2. DU-145 세포에서 멜리틴을 처리한 후 염증관련유전자 발현 및 NF-${\kappa}$B의 활성에 유의한 감소를 나타내었다. 3. DU-145 세포에서 NF-${\kappa}$B의 p50와 IKK들을 치환하여 작용기를 없애고 멜리틴을 처리하였을 경우에도 세포활성 및 NF-${\kappa}$B의 활성의 유의한 감소를 나타내었다.

Keywords

References

  1. Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002 ; 52 : 154-79. https://doi.org/10.3322/canjclin.52.3.154
  2. Feldman BJ, Feldman D. The develop- ment of androgenindependent prostate cancer. Nat. Rev. Cancer. 2001 ; 1 : 34-45. https://doi.org/10.1038/35094009
  3. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003 ; 349 : 366-81. https://doi.org/10.1056/NEJMra021562
  4. Santos AF, Huang H, Tindall DJ. The androgen receptor: a potential target for therapy of prostate cancer. Steroids. 2004 ; 69 : 79-85. https://doi.org/10.1016/j.steroids.2003.10.005
  5. Srilatha Swami, Aruna V Krishnan, Donna M Peehl, David Feldman. Genistein potentiates the growth inhibitory effects of 1.25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity. Molecular and Cellular Endocrinology 2005 ; 241 : 49-61. https://doi.org/10.1016/j.mce.2005.05.001
  6. Brown RL, Haley TL, West KA, Crabb JW. Pseudechetoxin: a peptide blocker of cyclic nucleotide-gated ion channels. Proc Natl Acad Sci USA. 1999 ; 96 : 754-9. https://doi.org/10.1073/pnas.96.2.754
  7. Sher E, Giovannini F, Boot J. Lang B. Peptide neurotoxins, small-celllung carcinoma andneurological paraneoplastic syndromes. Biochimie. 2000 ; 82 : 927-36. https://doi.org/10.1016/S0300-9084(00)01165-2
  8. van Lunteren E, Moyer M. Peptide toxin blockers of voltage-sensitive K+ channels: inotropic effects on diaphragm. J Appl Physiol. 1999 ; 3 : 1009-16.
  9. Park HJ, Lee SH, Son DJ, Oh KW, Kim KH, Song HS, Kim GJ, Oh GT, Yoon DY and Hong JT. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF -kappaB through interaction with the p50 subunit. Arthritis Rheum 2004 ; 50 : 3504-15. https://doi.org/10.1002/art.20626
  10. Holle L, Song W, Holle E, Wei Y, Wagner T and Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int J Oncol. 2003 ; 22 : 93-98.
  11. Park HJ, Lee YK, Song HS, Kim KJ, Son DJ, Lee JW and Hong JT. Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death. J Toxicol. Pub. Health. 2006 ; 22(1) : 31-7.
  12. HS Lee, HS Song. Bee venom inhibits LNCaP cell proliferation through induction of apoptosis via inactivation of NF -$\kappa$B. Journal of acupuncture and moxibustion 2008 ; 25(2) : 59-74.
  13. Dong ju Son, Mi Hee Park, Sang jin Chae et al. Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor KB. Mol Cancer Ther. 2007 ; 6(2) : 675-83. https://doi.org/10.1158/1535-7163.MCT-06-0328
  14. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000 ; 21 : 485-95. https://doi.org/10.1093/carcin/21.3.485
  15. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem, 2004 ; 91 : 70-99. https://doi.org/10.1002/jcb.10707
  16. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001 ; 20 : 225-43. https://doi.org/10.1023/A:1015583310759
  17. Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol 1995 ; 22(1 Suppl 1) : 324.
  18. Sub J, Payvandi F, Edelstein LC et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. 2002 ; 52 : 183-200. https://doi.org/10.1002/pros.10082
  19. Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF -kappaB. Prostate. 2004 ; 61 : 105-13. https://doi.org/10.1002/pros.20083
  20. Syrovets T, Gschwend JE, Buchele B et al. Inhibition of IkappaB kinase activity by acetylswellic acids promotes apoptosis in androgenndependent PC-3 prostate cancer cells in vitro and in vivo. J BioI Chem. 2005 ; 280 : 6170-80.
  21. Li Y, Sarkar FH. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res. 2002 ; 8 : 2369-77.